Summarized by Masters of Longevity from Science Daily - Health & Medicine.
Cord blood stem cell engineering leads to an article about producing ready-made T cells aimed at solid tumors, explaining the approach and potential uses.
Key Takeaways
- Researchers generated engineered cytotoxic T cells from cord blood hematopoietic stem cells that are mono-specific for tumor antigens.
- In mouse models a single dose of these off-the-shelf T cells controlled tumor growth and extended survival.
- The engineered cells avoided graft-versus-host disease, a common complication of donor-derived T-cell therapies.
